Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12576098 | Saponin containing extracts prepared from Hesperaloe useful in the treatment of non-human animals | 🖼🧊📄§ | 2026-03-17 | 2041-06-21 | 0 | 31 |
| 12570958 | Single- and multi-chain chimeric antigen receptors | 🖼🧊📄§ | 2026-03-10 | 2038-12-19 | 0 | 31 |
| 12570697 | Cyclic peptide useful in the treatment of cancer | 🖼🧊📄§ | 2026-03-10 | 2040-03-25 | 0 | 31 |
| 12569476 | Piperidine urea derivatives for use as inotropic agents | 🖼🧊📄§ | 2026-03-10 | 2045-02-21 | 0 | 31 |
| 12569547 | Immunogenic compositions against Clostridioides (Clostridium) difficile and methods thereof | 🖼🧊📄§ | 2026-03-10 | 2041-06-17 | 0 | 31 |
| 12569470 | Vasodilator and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-12-18 | 0 | 31 |
| 12569468 | Use of palovarotene in treatment against HBV virus | 🖼🧊📄§ | 2026-03-10 | 2041-06-01 | 0 | 31 |
| 12570686 | Chemical structures that control metabolic elimination of aminosterols | 🖼🧊📄§ | 2026-03-10 | 2045-02-18 | 0 | 31 |
| 12570709 | Self-assembling peptide amphiphiles displaying a transforming growth factor beta 1 (TGF-ß1) mimetic epitope | 🖼🧊📄§ | 2026-03-10 | 2042-07-28 | 0 | 31 |
| 12570668 | Single molecule compounds providing multi-target inhibition of BTK and other proteins and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2039-07-22 | 0 | 31 |
| 12571000 | Diaphragm-specific nucleic acid regulatory elements and methods and use thereof | 🖼🧊📄§ | 2026-03-10 | 2044-01-19 | 0 | 31 |
| 12569481 | Methods of treatment for gastrointestinal motility disorders | 🖼🧊📄§ | 2026-03-10 | 2041-06-11 | 0 | 31 |
| 12570617 | Use of triazole compound as ghrelin receptor agonist | 🖼🧊📄§ | 2026-03-10 | 2041-09-17 | 0 | 31 |
| 12570673 | c-Myc protein inhibitor, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-07-03 | 0 | 31 |
| 12569512 | Heparan sulfate (HS) oligosaccharides effect in liver ischemia reperfusion injury | 🖼🧊📄§ | 2026-03-10 | 2042-05-13 | 0 | 31 |
| 12569486 | Calmodulin inhibitors, CHK2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies | 🖼🧊📄§ | 2026-03-10 | 2044-02-13 | 0 | 31 |
| 12570725 | ZIKA antibodies and their use | 🖼🧊📄§ | 2026-03-10 | 2040-09-11 | 0 | 31 |
| 12569540 | Human recombinant hyposialylated erythropoietin, methods of purification and therapeutic uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-02-19 | 0 | 31 |
| 12570652 | Pyrrolidine compound and use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-05-14 | 0 | 31 |
| 12570756 | Methods of use of anti-CD45 antibodies and conjugates thereof | 🖼🧊📄§ | 2026-03-10 | 2041-10-22 | 0 | 31 |
| 12569463 | Method for treating diabetes | 🖼🧊📄§ | 2026-03-10 | 2042-09-22 | 0 | 31 |
| 12570661 | Isoform-specific aldehyde dehydrogenase inhibitors | 🖼🧊📄§ | 2026-03-10 | 2041-06-16 | 0 | 31 |
| 12569524 | Compositions and methods for preventing and treating antibiotic induced pathologies using probiotics in the biofilm state | 🖼🧊📄§ | 2026-03-10 | 2039-10-21 | 0 | 31 |
| 12569560 | Bismuth-gadolinium nanoparticles | 🖼🧊📄§ | 2026-03-10 | 2043-01-24 | 0 | 31 |
| 12569455 | Therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome | 🖼🧊📄§ | 2026-03-10 | 2041-02-05 | 0 | 31 |
| 12569572 | Messenger RNA therapy for the treatment of Friedreich's ataxia | 🖼🧊📄§ | 2026-03-10 | 2040-09-10 | 0 | 31 |
| 12570752 | Combination therapy with an anti BCMA antibody and a gamma secretase inhibitor | 🖼🧊📄§ | 2026-03-10 | 2040-04-09 | 0 | 31 |
| 12570603 | FABP4/5 inhibitors, methods of use and methods of making | 🖼🧊📄§ | 2026-03-10 | 2042-09-14 | 0 | 31 |
| 12569508 | Antimicrobial compositions and methods of use | 🖼🧊📄§ | 2026-03-10 | 2041-10-13 | 0 | 31 |
| 12571046 | Methods of detecting and treating multiple system atrophy | 🖼🧊📄§ | 2026-03-10 | 2041-05-28 | 0 | 31 |
| 12569545 | Method for treating and/or improving inflammatory intestinal disease | 🖼🧊📄§ | 2026-03-10 | 2043-05-24 | 0 | 31 |
| 12570719 | Chimeric antigen receptor comprising anti c-met antibody or antigen binding fragment thereof, and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-09-25 | 0 | 31 |
| 12569577 | PSMA-targeting imaging agents | 🖼🧊📄§ | 2026-03-10 | 2040-10-28 | 0 | 31 |
| 12570980 | Methods and compositions for treating inflammatory conditions associated with infectious disease | 🖼🧊📄§ | 2026-03-10 | 2045-04-02 | 0 | 31 |
| 12570755 | Anti-CD20 antibody and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2043-06-08 | 0 | 31 |
| 12570763 | Aerosolized mucus-tethering nanobodies to protect against viral and microbial contamination in closed and semi-enclosed spaces | 🖼🧊📄§ | 2026-03-10 | 2041-05-27 | 0 | 31 |
| 12570718 | PD-1-CD28 fusion proteins and their use in medicine | 🖼🧊📄§ | 2026-03-10 | 2041-10-29 | 0 | 31 |
| 12570738 | Multi-specific antibody with binding specificity for human IL-13 and IL-17 | 🖼🧊📄§ | 2026-03-10 | 2040-12-18 | 0 | 31 |
| 12569543 | Semaglutide in cardiovascular conditions | 🖼🧊📄§ | 2026-03-10 | 2037-04-28 | 0 | 31 |
| 12570655 | Cysteine covalent modifiers of AKT1 and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2045-05-30 | 0 | 31 |
| 12570689 | Purification of GLP-1 analogues | 🖼🧊📄§ | 2026-03-10 | 2040-02-05 | 0 | 31 |
| 12571796 | Viral exposure signature for detection of early stage hepatocellular carcinoma | 🖼🧊📄§ | 2026-03-10 | 2040-10-09 | 0 | 31 |
| 12569439 | Bottom-up assembly of synthetic extracellular vesicles | 🖼🧊📄§ | 2026-03-10 | 2041-01-29 | 0 | 31 |
| 12569484 | Use of phosphodiesterase 5 inhibitor in preparation of medicament for resisting fibrotic diseases | 🖼🧊📄§ | 2026-03-10 | 2040-07-29 | 0 | 31 |
| 12570731 | Methods for treating cancer with an anti-apo B100 antibody | 🖼🧊📄§ | 2026-03-10 | 2040-11-12 | 0 | 31 |
| 12569453 | Use of tapinarof for the treatment of atopic dermatitis | 🖼🧊📄§ | 2026-03-10 | 2043-02-02 | 0 | 31 |
| 12569495 | Inhibitors of porcine reproductive and respiratory syndrome virus | 🖼🧊📄§ | 2026-03-10 | 2041-05-28 | 0 | 31 |
| 12570733 | Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules | 🖼🧊📄§ | 2026-03-10 | 2042-06-30 | 0 | 31 |
| 12570728 | Combinations of antibodies and bispecific antibodies comprising antigen-binding specifically recognizing Pseudomonas PcrV and Psl | 🖼🧊📄§ | 2026-03-10 | 2041-11-18 | 0 | 31 |
| 12570730 | Chimeric antigen receptors for direct and indirect targeting of fibronectin-positive tumors | 🖼🧊📄§ | 2026-03-10 | 2040-07-17 | 0 | 31 |